David K McClintock

Title: The Innovative Contributions of David K McClintock

Introduction

David K McClintock is a notable inventor based in Ramsey, NJ (US). He has made significant contributions to the field of vaccine development, particularly in the prevention of diseases caused by Bordetella pertussis. With a total of four patents to his name, McClintock's work has had a profound impact on public health.

Latest Patents

One of McClintock's latest patents focuses on efficacious vaccines against Bordetella pertussis. This invention is directed to a vaccine that comprises pertussis antigens, including filamentous hemagglutinin, detoxified lymphocytosis promoting factor, and a 69 kilodalton outer membrane protein. These antigens are individually purified before being combined to form the vaccine. The invention also allows for the combination of these antigens in various ratios, including those not possible in whole cell or co-purified acellular pertussis vaccines. Furthermore, the pertussis antigens may be combined with other individually purified pertussis antigens, structural components, adjuvants, stabilizers, and non-pertussis vaccine components.

Career Highlights

David K McClintock is associated with the American Cyanamid Company, where he has been able to apply his innovative ideas in vaccine research and development. His work has contributed to advancements in immunology and public health.

Collaborations

Throughout his career, McClintock has collaborated with notable colleagues, including Thomas G Eckhardt and John W Gotto. These collaborations have further enhanced the quality and impact of his research.

Conclusion

David K McClintock's contributions to vaccine development exemplify the importance of innovation in public health. His work continues to influence the field and improve health outcomes for many.